Charles River Laboratories shares owned by Raymond James & Associates
Quarter-by-quarter ownership of Charles River Laboratories (CRL) shares owned by Raymond James & Associates
from 13F filings
Historical chart of Raymond James & Associates investment in Charles River Laboratories
Tip: Access up to 7 years of quarterly data
All positions including Charles River Laboratories held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Charles River Laboratories by Raymond James & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $49M | 249k | 196.97 |
| 2024-06-30 | $51M | 248k | 206.58 |
| 2024-03-31 | $67M | 248k | 270.95 |
| 2023-12-31 | $58M | 244k | 236.40 |
| 2023-09-30 | $49M | 252k | 195.98 |
| 2023-06-30 | $52M | 246k | 210.25 |
| 2023-03-31 | $47M | 232k | 201.82 |
| 2022-12-31 | $49M | 224k | 217.90 |
| 2022-09-30 | $46M | 232k | 196.80 |
| 2022-06-30 | $27M | 125k | 213.97 |
| 2022-03-31 | $33M | 116k | 283.97 |
| 2021-12-31 | $81M | 214k | 376.78 |
| 2021-09-30 | $74M | 180k | 412.67 |
| 2021-06-30 | $63M | 172k | 369.92 |
| 2021-03-31 | $46M | 160k | 289.83 |
| 2020-12-31 | $33M | 130k | 249.86 |
| 2020-09-30 | $24M | 107k | 226.45 |
| 2020-06-30 | $16M | 93k | 174.35 |
| 2020-03-31 | $10M | 81k | 126.21 |
| 2019-12-31 | $12M | 75k | 152.76 |
| 2019-09-30 | $9.3M | 70k | 132.37 |
| 2019-06-30 | $8.2M | 58k | 141.91 |
| 2019-03-31 | $5.6M | 38k | 145.24 |
| 2018-12-31 | $3.7M | 32k | 113.19 |
| 2018-09-30 | $4.2M | 31k | 134.54 |
| 2017-12-31 | $531k | 4.8k | 109.53 |
| 2017-09-30 | $434k | 4.0k | 107.91 |
| 2017-06-30 | $378k | 3.7k | 101.23 |
| 2017-03-31 | $496k | 5.5k | 89.90 |
| 2016-09-30 | $2.5M | 31k | 83.34 |
| 2016-06-30 | $2.1M | 25k | 82.42 |
| 2015-09-30 | $2.1M | 33k | 63.52 |
| 2015-06-30 | $1.6M | 22k | 70.34 |
More positions owned by Raymond James & Associates
Home Depot (HD)
View all positions for Raymond James & Associates